If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
Understanding
Niemann–Pick
disease type C
and its potential
treatment
J. E. Wraith and J. Imrie
© 2007 by Blackwell Publishing
Blackwell Publishing, Inc., 350 Main Street, Malden, Massachusetts 02148-5020, USA
Blackwell Publishing Ltd, 9600 Garsington Road, Oxford OX4 2DQ, UK
Blackwell Publishing Asia Pty Ltd, 550 Swanston Street, Carlton, Victoria 3053, Australia
ISBN: 978-1-4051-5702-5
Set in Franklin Gothic Medium Condensed by Sparks, Oxford -- www.sparks.co.uk
Printed and bound in the UK by rpm print and design, Chichester
This publication has been made available through an educational grant from Actelion Pharmaceuticals Ltd
Contents
Glossary of Terms 4
Niemann–Pick Disease Type C: A Scientist's Perspective
Understanding Niemann–Pick disease type C and its
© 2007 by Blackwell Publishing Blackwell Publishi
Contents Glossary of Terms
Glossary of Terms Term
Niemann–Pick Disease Type C: A Scientist's Perspe
A Call to Action: The Patient Association View W
Niemann–Pick Disease in Summary NPC is an extrem
History: Niemann–Pick Disease Types and Nomenclat
condition as it is biochemically and clinically i
Mutations NPC1 The NPC1 gene, mapped to chromosom
Patterns of inheritance NPC is inherited in an au
Pathophysiology NPC defects in lipid trafficking
Figure 2. Cholesterol trafficking defect in cultur
Neuropathology At the gross level, the brain ofte
Figure 4. Neurofibrillary tangles in NPC (Reproduc
Figure 5. Alternative models for the role of NPC1
Analyses of genome-wide expression patterns have
Clinical Manifestations Signs and symptoms In li
NPC and has been estimated to occur in 20–50% of
Prognosis The variability of NPC presentations pr
Diagnostic Strategies Accurate diagnosis of NPC
Filipin staining is employed to identify any fluor
Figure 8. MRI and H-MRSI in control and NPC brain
Evaluations following initial diagnosis Patients
Where to Refer: Specialist Care Centres Given th
medical specialists, as their child has complicat
Healthcare Support The role of patient associati
Treatment Strategies in NPC There is no definitiv
Cell-signalling targets Studies have demonstrated
Table 6. Key parameters for establishing treatmen
supportive treatments. It is therefore vital to r
References 1.Patterson MC, Vanier MT, Suzuki
27. Fernandez-Valero EM, Ballart A, Iturriaga C e
49. Watari H, Blanchette-Mackie EJ, Dwyer NK et a
73. Sun X, Marks DL, Park WD et al. Niemann–Pick
95. Mellon SH, Griffin LD. Neurosteroids: bioc
ISBN: 978-1-4051-8269-0